Beyond FSP1 there are therapeutic opportunities across the CoQ 10 oxidoreductase network While FSP1 currently has the strongest targetability signal, other CoQ 10 oxidoreductases may be therapeutically leveraged in defined genetic, metabolic or tissue contexts: (1) DHODH axis (mitochondrial defense in select contexts): DHODH connects pyrimidine synthesis to mitochondrial CoQ reduction, and in some settings, DHODH inhibition has been proposed to heighten ferroptosis sensitivity, especially in GPX4-low states
FDA-approved GLP-1 receptor agonists for weight loss include: Wegovy pill ( semaglutide ): a daily oral tablet you take in the morning on an empty stomach, at least 30 minutes before any food, water, or other medications
Best paired with: Cellular Light Panel, Elysium Light Bed, Lymphatic Drainage Therapy, The Glow Up IV Drip Supports a natural-looking tan while promoting libido, energy, and overall vitality
For individuals concerned about preserving lean mass, especially during periods of caloric restriction, sermorelin is not a weight-loss medication
